Search
for
Sort by
Research 91–120 of 1000+
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis
- Inhibitors of 5α-Reductase in the Treatment of Benign Prostatic Hyperplasia
- Actions of 5α-reductase inhibitors on the epididymis
- Clinical application of 5α-reductase inhibitors
- Safety concerns regarding 5α reductase inhibitors for the treatment of androgenetic alopecia
- Evaluation of 5α-reductase inhibitory activity of certain herbs useful as antiandrogens
- Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Benzo[<i>c</i>]quinolizin-3-ones: A Novel Class of Potent and Selective Nonsteroidal Inhibitors of Human Steroid 5α-Reductase 1
- Inhibitors of 5α -Reductase Type I in LNCaP Cells from the Roots of Angelica koreana
- Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Effect of the 5α-reductase enzyme inhibitor dutasteride in the brain of intact and parkinsonian mice
- Enhanced skin permeation of 5α-reductase inhibitors entrapped into surface-modified liquid crystalline nanoparticles
- Synthesis and 5α-reductase inhibitory activity of 8-substituted benzo[ƒ]quinolinones derived from palladium mediated coupling reactions
- Early embryonic exposure of freshwater gastropods to pharmaceutical 5-alpha-reductase inhibitors results in a surprising open-coiled “banana-shaped” shell
- Is there a role for 5α‐reductase inhibitors in transgender individuals?
- Synthesis and activity of 8-substituted benzo[c]quinolizin-3-ones as dual inhibitors of human 5α-reductases 1 and 2
- Design, synthesis and biological evaluation of novel androst-3,5-diene-3-carboxylic acid derivatives as inhibitors of 5α-reductase type 1 and 2
- Co-administration of 5α-reductase Inhibitors Worsens the Adverse Metabolic Effects of Prescribed Glucocorticoids
- Pharmacodynamic modeling of finasteride, a 5 alpha-reductase inhibitor.
- Macular Abnormalities Associated With 5α-Reductase Inhibitor
- Synthesis and biological evaluation of esters of 16-formyl-17-methoxy-dehydroepiandrosterone derivatives as inhibitors of 5α-reductase type 2
- Activity of steroid 4 and derivatives 4a–4f as inhibitors of the enzyme 5α-reductase 1
- Clinical use of 5α-reductase inhibitors
- Role of 5α-reductase inhibitors in androgen-stimulated skin disorders.
- Contraindicated use of 5-alpha-reductase inhibitors in women
- In silico screening of effective inhibitor of 5α-reductase type 1 for androgenic alopecia treatment